$84.08
arrow_drop_down1.22%Key Stats | |
---|---|
Open | $85.33 |
Prev. Close | $85.12 |
EPS | 1.32 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
LOW | HIGH | |
---|---|---|
Day Range | 83.73 | 86.04 |
52 Week Range | 73.68 | 99.56 |
Ratios | |
---|---|
EPS | 1.32 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Gene Therapy Market Size to Reach USD 54.39 Billion By 2032 with CAGR of 23.12%, Boosted by Rising Genetic Disorders and Advances in CRISPR Technology
Hemophilia Market Size to Surpass US$ 23.99 Billion by 2033, The Brainy Insights
Peering Into Biomarin Pharmaceutical's Recent Short Interest - Biomarin Pharmaceutical (NASDAQ:BMRN) - Benzinga
Cracking The Code: Understanding Analyst Reviews For Biomarin Pharmaceutical
Mirum Pharmaceuticals (MIRM) Soars 27.3%: Is Further Upside Left in the Stock?
BioMarin (BMRN) Down 7.6% Since Last Earnings Report: Can It Rebound?